Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter ...
Zacks.com on MSN6h
Biotech Stock Roundup: REGN Up on Q4 Results, VRTX, AXSM Gain on Drug Approval
It was a busy week for the biotech sector as the fourth-quarter earnings season kicked in. While Regeneron REGN gained following the announcement, Amgen AMGN was in the red. Meanwhile, other pipeline ...
pharmaphorum23h
Regeneron gene therapy restores hearing in deaf child
Regeneron’s gene therapy for otoferlin-related ... at the American Society of Gene and Cell Therapy (ASGCT) annual conference. DB-OTO is designed to correct the mutations in the otoferlin ...